Characterization, in vitro and in vivo studies on primaquine diphosphate liposomes

Journal of Microencapsulation

Volumn 12, Issue 5, 1995, Pages 469-485

  Arica, B ^a   ozer A Y ^a   Ercan, M T ^a   Hincal, A A ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Drug release; Liposome; Malaria; Primaquine diphosphate; Technetium 99 m

Indexed keywords

ANTIMALARIAL AGENT; CHOLESTEROL; LIPOSOME; PHOSPHOLIPID; PRIMAQUINE DERIVATIVE; PRIMAQUINE DIPHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG LIVER LEVEL; DRUG RELEASE; DRUG TISSUE LEVEL; IN VITRO STUDY; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; LUNG; MICROENCAPSULATION; MOUSE; NONHUMAN; PANCREAS; PARTICLE SIZE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; SPLEEN; STOMACH;

ANIMAL; ANTIMALARIALS; DRUG CARRIERS; DRUG COMPOUNDING; ISOTOPE LABELING; KINETICS; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; PARTICLE SIZE; PRIMAQUINE; QUALITY CONTROL; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 0029083223     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.3109/02652049509006778     Document Type: Article

References (44)

1. The effect of lipid composition upon the encapsulation and in vitro leakage of metoproteranol sulphate from 0.2 mm in diameter, extruded multilamellar liposomes
2. The therapy of leishmaniasis: superior efficacies of liposome encapsulated drugs
3. Therapeutic potential of liposomes as carriers in leishmaniasis, malaria vaccine
4. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria
5. Diffusion of univalent ions across the lamellae of swollen phospholipids
6. Primaquine disposition in the isolated perfused rat liver: effect of mefloquine induced bile flow reduction
7. Influence of lipid composition on ionic strength on the physical stability of liposomes
8. Interaction of liposomes with Kupffer cells
9. Effects of ammonium chloride and chloroquine on endocytic uptake of liposomes by Kupffer cells in vitro
10. Preparation and characterization of liposome encapsulated praziquantel for prophylactic treatment of schistozomiazis
11. Labelling and evaluation of 99mTccyclophosphamide for tumour visualization
12. Rapid determination hydrolyzed-reduced technetium 99m in particulate radiopharmaceuticals
13. Square root of time dependence of matrix formulations with low drug content
14. Lysosomal location of b-fuctofuranosidase-containing liposomes injected into rats: some implication in treatment of genetic disorders
15. Carrier-linked primaquine in the chemotherapy of malaria
16. Tissue distribution of primaquine in the rat
17. The influence of extrusion of multilamellar vesicles through polycarbonate membranes on particle size, particle size distribution and number of bilayers
18. Liposomes as a carrier for methotraxate
19. Preparation of tin albumin nanospheres for labelling with 99mTc and application in liver
20. New method of drug delivery
21. Subacute toxicity of primaquine in dogs, monkeys and rats
22. Poly(diethylmethylidene malonate) nanoparticles as primaquine delivery system to liver
23. Preparation of defined size distribution by extrusion through polycarbonate membranes
24. In vivo studies of amphoterisin B liposomes derived from proliposomes: effect of formulation on toxicity and tissue disposition of the drug in mice
25. Classification of controlled release systems
26. Chloroquine blood levels after administration of the liposome-encapsulated drug in relation to therapy of the murine malaria
27. Primaquine liposomes in the chemotherapy of experimental murine malaria
28. The disposition of free and liposomally encapsulated antimalarial primaquine in mice. I
29. Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine enantiomers and two putative metabolites. I
30. Effects of dose and vesicle size on the pharmacokinetics of liposomes
31. Surface areas of lipid membranes
32. Comparative properties and methods of preparafion of lipid vesicles
33. The size reduction of liposomes with a high pressure homogenizer (Microfluidizer TM). Characterization of prepared dispersions and comparison with conventional methods
34. Development of new derivatives of primaquine by association with lysosomotropic carriers
35. Preparation of liposome encapsulated anti-tumor drugs and in vitro drug release
36. Quantitative determination of phospholipis in blood serum or plasma by a nondestructive method
37. In vitro interaction of sized and insized liposome vesicles with high density lipoproteins
38. Drug release rate method for liposome preparation
39. Liposomes as a drug delivery system